Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis
Pharmacoepidemiology and Drug Safety · 2025-10 · 34 (10)
DOI: 10.1002/pds.70225 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 25.09.2025. Verfasst von Desalegn Getnet Demsie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia. Hauptthemen laut MEDLINE: Anticoagulants, Hemorrhage, Thromboembolism, Warfarin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Warfarin use in Sub‐Saharan Africa is associated with elevated risks of thromboembolic events and bleeding, but precise prevalence estimates are lacking. This systematic review and meta‐analysis aimed to quantify the prevalence of bleeding and thromboembolic events among patients on warfarin in Sub‐Saharan Africa.
Methods
Comprehensive searches were conducted in MEDLINE via Ovid, PubMed, Embase via Ovid, Scopus, and Google Scholar to identify relevant studies. Primary outcomes included major and minor bleeding events, while thromboembolic events were secondary outcomes. Meta‐analysis was conducted using RStudio version 4.3.3 with the meta and metaprop packages. Proportions were transformed using the Freeman–Tukey double arcsine method, and meta‐regression was performed with the metafor package's escal , rma , and res functions. Publication bias was assessed via funnel plots and Egger's test, with a p value < 0.05 indicating potential bias. Sensitivity analysis was conducted through leave‐one‐out analysis. The review was performed in adherence to PRISMA guidelines.
Results
We identified 10 observational studies for inclusion in this systematic review and meta‐analysis. Egger's test indicated no publication bias. Meta‐regression analysis showed that moderators (publication year, sample size, setting, and follow‐up duration) did not significantly impact bleeding risk. The pooled prevalence of major and minor bleeding was 18% (95% CI: 0.10–0.27; I 2 : 96%, prediction interval: 0.00–0.53), with rates ranging from 4% to 46%. Thromboembolic events occurred in 7% of warfarin users (95% CI: 0.01–0.07).
Conclusion
Warfarin therapy in Sub‐Saharan Africa is associated with considerable bleeding and thromboembolic risks. The robustness of these findings was confirmed through meta‐regression and sensitivity analyses, underscoring the need for improved therapeutic monitoring and safety strategies in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, College of Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
- St. Peter Hospital, Addis Ababa, Ethiopia.
- Department of Pharmacology, Biomedical Division, and Center for Equity in Global Surgery, University of Global Health Equity, Kigali, Rwanda.
ORCID-Profile: Desalegn Getnet Demsie
Zitieren
APA
Demsie, D. G., Addisu, Z. D., Tafere, C., Bahiru, B., Yismaw, M. B., Mihret, G., & Berhe, D. F. (2025). Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis. Pharmacoepidemiology and Drug Safety, 34(10). https://doi.org/10.1002/pds.70225
Vancouver
Demsie DG, Addisu ZD, Tafere C, Bahiru B, Yismaw MB, Mihret G, et al. Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis. Pharmacoepidemiology and Drug Safety. 2025;34(10). doi:10.1002/pds.70225
BibTeX
@article{Demsie2025,
author = {Demsie, Desalegn Getnet and Addisu, Zenaw Debasu and Tafere, Chernet and Bahiru, Bereket and Yismaw, Malede Berihun and Mihret, Getahun and Berhe, Derbew Fikadu},
title = {Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
volume = {34},
number = {10},
doi = {10.1002/pds.70225}
}
EUVIMED